PLUS1
270.475
4.47 (1.68%)
4.47 (1.68%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Techne Corporation | TECH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 4.47 | 1.68% | 270.475 | 264.90 | 272.89 | 266.17 | 266.01 | 12:18:37 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 270.49 | 271.06 | 0.57 | 0.21% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,476 | 44,458 | $ 268.67 | $ 11,944,717 | 268,928 | 155.17 - 287.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:18:34 | 1 | $ 270.75 | USD |
Bio Techne Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 10.39B | 38.22M | 33.87M | $ 714.01M | $ 176.93M | 2.47 | 54.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.28 | 0.47% | - | - |
Bio Techne News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/11/2020 | 07:00 | PR Newswire (US) | Bio-Techne And ZERO - The End Of Prostate Cancer Announce.. |
| 6/09/2020 | 07:00 | PR Newswire (US) | Bio-Techne Continues to Expand Its Portfolio to Support.. |
| 6/08/2020 | 07:00 | PR Newswire (US) | Bio-Techne Announces Release of GMP ProDots Proteins to.. |
| 6/02/2020 | 17:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/01/2020 | 17:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/01/2020 | 17:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 5/29/2020 | 07:04 | Edgar (US Regulatory) | Specialized Disclosure Report (sd) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TECH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 253.93 | 272.89 | 247.51 | 259.92 | 198,017 | 16.55 | 6.52% |
| 1 Month | 257.88 | 272.89 | 241.10 | 255.00 | 224,765 | 12.60 | 4.88% |
| 3 Months | 200.30 | 287.98 | 189.33 | 245.76 | 282,427 | 70.18 | 35.03% |
| 6 Months | 220.56 | 287.98 | 155.17 | 221.51 | 238,402 | 49.92 | 22.63% |
| 1 Year | 212.90 | 287.98 | 155.17 | 214.82 | 190,544 | 57.58 | 27.04% |
| 3 Years | 118.13 | 287.98 | 112.33 | 179.23 | 183,899 | 152.35 | 128.96% |
| 5 Years | 96.89 | 287.98 | 79.95 | 148.01 | 183,017 | 173.59 | 179.16% |
Bio Techne Description
| Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies, and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators, and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits. The company is split into two reporting segments namely, Protein Sciences segment and Diagnostics and Genomics segment. The Protein Sciences segment generates maximum revenue for the company. |
